Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine

China Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine, Find details about China Nifedipine, 21829-25-4 from Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine

Model NO.
Nifedipine
Color
Yellow Crystalline Powder
Density
1.271
Molecular Formula
C17h18n2o6
Formula Weight
346.335
CAS
21829-25-4
Storage Condition
Seal and Store in a Cool, Dry Place
Trademark
HNB
Transport Package
Aluminium Foil Bag and Carton
Specification
98% Nifedipine
Origin
China
HS Code
2933290090
Model NO.
Nifedipine
Color
Yellow Crystalline Powder
Density
1.271
Molecular Formula
C17h18n2o6
Formula Weight
346.335
CAS
21829-25-4
Storage Condition
Seal and Store in a Cool, Dry Place
Trademark
HNB
Transport Package
Aluminium Foil Bag and Carton
Specification
98% Nifedipine
Origin
China
HS Code
2933290090
Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine

Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine
 

Name  :     Nifedipine
Shape :     Light Yellow crystalline powder

Use for :    

For the prevention and treatment of coronary heart disease angina pectoris, especially variant angina pectoris and angina pectoris caused by coronary artery spasm.It has no adverse effect on respiratory function, so it is suitable for patients with angina pectoris suffering from respiratory obstructive diseases, and its efficacy is better than that of β-receptor antagonists.It is also applicable to various types of hypertension, and has a good effect on intractable and severe hypertension.Because it can reduce afterload, it also has a good effect on refractory congestive heart failure, and is suitable for long-term use.

              

                   

             

              Nifedipine, also known as 1, 4-dihydro-2, 6-dimethyl-4 -(2-nitrophenyl)-3, 5-pyridine dicarboxylate, is a dihydropyridine calcium antagonist used for the prevention and treatment of coronary heart disease angina pectoris, especially variant angina pectoris and angina pectoris caused by coronary artery spasms.It has no adverse effect on respiratory function, so it is suitable for patients with angina pectoris suffering from respiratory obstructive diseases, and its efficacy is better than that of β-receptor antagonists.It is also applicable to various types of hypertension, and has a good effect on intractable and severe hypertension.Because it can reduce afterload, it also has a good effect on refractory congestive heart failure, and is suitable for long-term use.


 

NameCASmoleculardensity
Nifedipine21829-25-4C17H18N2O61.271
 
Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine           Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine

 

 

 

 

Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 NifedipinePharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine

Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine

Pharmaceutical Raws 99.9% Powder CAS 21829-25-4 NifedipinePharmaceutical Raws 99.9% Powder CAS 21829-25-4 NifedipinePharmaceutical Raws 99.9% Powder CAS 21829-25-4 NifedipinePharmaceutical Raws 99.9% Powder CAS 21829-25-4 NifedipinePharmaceutical Raws 99.9% Powder CAS 21829-25-4 Nifedipine